Case Series


Pneumomediastinum in COVID-19 critically ill patients: A case series of unusual complication from a Tunisian intensive care unit

,  ,  ,  ,  ,  

1 Medical Intensive Care Unit, Ibn El Jazzar University Hospital, Kairouan, Tunisia

2 Pulmonology Department, El Jazzar University Hospital, Kairouan, Tunisia

Address correspondence to:

Jihene Ayachi

Road Iskander Makdouni n°17, Kairouan 3100,

Tunisia

Message to Corresponding Author


Article ID: 101326Z01DB2022

doi: 10.5348/101326Z01DB2022CS

Access full text article on other devices

Access PDF of article on other devices

How to cite this article

Braiek DB, Mighri I, Zorgati H, Jazia RB, Kacem A, Ayachi J. Pneumomediastinum in COVID-19 critically ill patients: A case series of unusual complication from a Tunisian intensive care unit. Int J Case Rep Images 2022;13(2):50–57.

ABSTRACT


Introduction: Coronavirus disease 2019 (COVID-19) is a new rapidly emerging and ever-evolving disease that clinicians continue to detect new manifestations and complications daily since December 2019. Pneumomediastinum, a potentially life-threatening condition, is an uncommon complication of acute respiratory distress syndrome from viral infections. By presenting this case series, we highlight that pneumomediastinum (PM) can complicate the course of a severe COVID-19 infection.

Case Series: We identified four critically ill patients, two men and two women, aged between 50 and 70 years old. None of them had any underlying lung disease. On admission all cases were in acute respiratory distress syndrome. Three patients were under positive pressure ventilation both invasive (n = 2/4) and non-invasive (n = 1/4) at the time of the event; however, one patient had a spontaneous PM without any exposure to mechanical ventilation. Chest computed tomography scan (chest CT scan) was performed for all patients showing a pulmonary involvement estimated moderate (n = 3/4) to severe (n = 1/4), PM (n = 4/4) and subcutaneous emphysema (n = 2/4). For ventilated patients, PM was diagnosed 3 to 7 days after initiation of mechanical ventilation. The highest positive end-expiratory pressure was 10 cmH2O for patients receiving invasive mechanical ventilation, while 5 cmH2O for patient who had developed PM on non-invasive ventilation. The PM was managed by conservative therapy in all of the cases with reducing airway pressure.

Conclusion: Our findings suggest that PM is secondary to inflammatory response due to COVID-19 and mostly triggered by the use of positive pressure ventilation and it is associated with poor outcome in critically ill COVID-19 patients.

Keywords: COVID-19, Intensive care unit, Pneumomediastinum, Positive pressure respiration

SUPPORTING INFORMATION


Author Contributions

Dhouha Ben Braiek - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Imen Mighri - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Final approval of the version to be published

Hend Zorgati - Acquisition of data, Analysis of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published

Rahma Ben Jazia - Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Ameni Kacem - Acquisition of data, Analysis of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published

Jihene Ayachi - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Guarantor of Submission

The corresponding author is the guarantor of submission.

Source of Support

None

Consent Statement

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Conflict of Interest

Authors declare no conflict of interest.

Copyright

© 2022 Dhouha Ben Braiek et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.